CaffeenHeadache™️ Profile picture
Jophas (Joe for short) from the WI part of MI
May 6 12 tweets 7 min read
🧵China isn't the only..."red flag" 🇨🇳 involved in Gain-of-Function-adjacent research when it comes to Hantavirus...

None other than Ukraine - where there "are no biolabs".
🇺🇦🇺🇦🇺🇦🇸🇩🇸🇩🇸🇩 Image
Image
2/ The U.S.–Ukraine “biolab” record starts with BTRP:

DTRA says the program partnered with Ukraine from 2005 to improve peaceful biological detection/diagnostic capacity and reduce risks from dangerous pathogens. (1)
gusquixote.com/article/part-t…
May 6 14 tweets 6 min read
🧵Hantavirus an Anthony Fauci Gain-of-Function Frankenstein gone wrong?

Public records show U.S.–China overlap in hantavirus clinical treatment research, surveillance, molecular epidemiology, phylogenetics, reservoir-host research, and natural reassortment/pathogenicity studies. 2/ Hantavirus U.S.–China overlap isn’t one visible “joint GOF program.”

Public record points to cooperation in treatment trials, surveillance, molecular epidemiology, host-jump ecology, reassortment analysis, and countermeasures. (1)Image
May 6 14 tweets 5 min read
1/ Hantavirus spillover research in China with U.S.-affiliated scientists clusters into 3 lanes:

Chinese human HFRS surveillance.
Chinese rodent/isolate genetics.
Ecological risk modeling.

“American scientists” here means U.S. institutional affiliation at publication, not confirmed nationality. (1)Image 2/ One early U.S.-China trail runs through USAMRIID.

In 1993, S.Y. Xiao and C.S. Schmaljohn characterized HV114, a hantavirus isolated from an HFRS patient in Hubei, China, using antigenic comparison and M-segment sequencing. (1)Image